User Acceptability Patterns for Mefloquine and Doxycycline Malaria Chemoprophylaxis
Authors:
- Margaret A. PhillipsMPMargaret A. Phillips
- Robert B. KassRKRobert B. Kass
Open Access
- 1 March 1996
- journal article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 3 (1) , 40-45
Abstract
Background. The objective of this study was to profile the user acceptability (self-reported adverse effects and compliance patterns) for mefloquine (2Keywords
This publication has 9 references indexed in Scilit:
- Gender as a Risk Factor for Adverse Events to MedicationsDrugs, 1995
- Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellersBMJ, 1994
- Antimalarial mefloquineMedical Journal of Australia, 1994
- Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East AfricaThe Lancet, 1993
- Long-term malaria prophylaxis with weekly mefloquineThe Lancet, 1993
- Confounding in Studies of Adverse Reactions to VaccinesAmerican Journal of Epidemiology, 1992
- Effect of age and gender on the activity of human hepatic CYP3ABiochemical Pharmacology, 1992
- The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjectsEuropean Journal of Clinical Pharmacology, 1987
- Age‐ and Gender‐Related Differences in Diazepam PharmacokineticsThe Journal of Clinical Pharmacology, 1979